Related Experiment Video
Updated: Jun 21, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Nanoparticles in prevention of protein glycation
1School of Bioengineering Sciences and Research, MIT ADT University, Pune, India.
Abstract:
Advanced glycation end products (AGEs) are formed by the non-enzymatic attachment of carbohydrates to a biological macromolecule. These AGEs bind to their cognate receptor called receptor for AGEs (RAGEs), which becomes one of the important causal factors for the initiation and progression of several diseases. A deep understanding into the pathways of RAGEs will help in identifying novel intervention modalities as a part of new therapeutic strategies. Although several approaches exist to target this pathway using small molecules, compounds of plant origin etc, nanoparticles have proven to be a critical method, given its several advantages. A high bioavailability, biocompatibility, ability to cross blood brain barrier and modifiable surface properties give nanoparticles an upper edge over other strategies. In this chapter, we will discuss AGEs, their involvement in diseases and the nanoparticles used for targeting this pathway.
Insights
Advanced glycation end products (AGEs) contribute to disease by binding to the receptor for AGEs (RAGEs). Nanoparticles offer a promising therapeutic strategy for targeting the RAGE pathway due to their enhanced bioavailability and delivery capabilities.
Area of Science:
- Biochemistry and Molecular Biology
- Nanomedicine
- Pathophysiology
Background:
- Advanced glycation end products (AGEs) form via non-enzymatic carbohydrate attachment to macromolecules.
- AGEs bind to the receptor for AGEs (RAGEs), a key factor in disease initiation and progression.
Purpose of the Study:
- To explore the role of AGEs and RAGEs in disease pathogenesis.
- To review nanoparticle-based strategies for targeting the AGE-RAGE pathway.
Main Methods:
- Review of literature on AGEs, RAGEs, and nanoparticle applications.
- Discussion of nanoparticle advantages in therapeutic targeting.
Main Results:
- AGE-RAGE interactions are implicated in various disease processes.
- Nanoparticles present significant advantages for targeting the AGE-RAGE pathway.
Conclusions:
- Understanding the AGE-RAGE axis is crucial for developing novel therapeutic interventions.
- Nanoparticles offer a promising platform for advanced therapeutic strategies against AGE-RAGE-mediated diseases.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Proteoglycans

